LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 58 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,000 | -23.5% | 47,998 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -48.5% | 47,998 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $33,000 | -62.5% | 47,998 | +26.3% | 0.00% | 0.0% |
| Q4 2021 | $88,000 | -49.4% | 37,998 | 0.0% | 0.00% | -66.7% |
| Q3 2021 | $174,000 | +3.0% | 37,998 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $169,000 | -39.0% | 37,998 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $277,000 | -4.5% | 37,998 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $290,000 | -15.9% | 37,998 | 0.0% | 0.01% | -25.0% |
| Q3 2020 | $345,000 | +7.5% | 37,998 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $321,000 | +70.7% | 37,998 | 0.0% | 0.01% | +60.0% |
| Q1 2020 | $188,000 | -15.7% | 37,998 | +22.6% | 0.01% | 0.0% |
| Q4 2019 | $223,000 | – | 31,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 6,466,783 | $69,906,000 | 1.33% |
| Board of Trustees of The Leland Stanford Junior University | 949,443 | $10,264,000 | 1.11% |
| Lion Point Capital, LP | 500,000 | $5,405,000 | 0.60% |
| Sio Capital Management, LLC | 122,536 | $1,325,000 | 0.43% |
| Redmile Group, LLC | 749,026 | $8,097,000 | 0.27% |
| SAMLYN CAPITAL, LLC | 639,977 | $6,918,000 | 0.17% |
| Stanley-Laman Group, Ltd. | 19,530 | $211,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,378,475 | $14,901,000 | 0.04% |
| FRANKLIN RESOURCES INC | 700,000 | $7,567,000 | 0.00% |
| Jefferies Group LLC | 10,618 | $115,000 | 0.00% |